Dr. Maria Cancio, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Area of expertise
Bone Marrow Failure Syndrome
Maria Cancio, MD has run 2 trials for Bone Marrow Failure Syndrome. Some of their research focus areas include:
Hemoglobin Disorders
Maria Cancio, MD has run 1 trial for Hemoglobin Disorders. Some of their research focus areas include:
Affiliated Hospitals
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering At Basking Ridge (Consent Only)
Clinical Trials Maria Cancio, MD is currently running
Cord Blood Transplant
for Blood Cancers
This is a single-arm study to investigate 1-year treatment related mortality (TRM) in patients with life threatening non-malignant and malignant hematologic disorders who do not have a matched related donor for allogeneic transplantation.
Recruiting
1 award
Phase 2
Immune Suppression Treatment
for Sickle Cell Disease
Hematopoietic Cell Transplantation/HCT involves receiving healthy blood-forming cells (stem cells) from a donor to replace the diseased or damaged cells in participants' bone marrow. The researchers think giving participants treatment with fludarabine and dexamethasone, drugs that lower the activity of the body's immune system (immune suppression), before standard conditioning therapy and HCT may help prevent serious side effects, including graft failure and GvHD. In this study, depending on how participants' body responds to the fludarabine and dexamethasone, the study doctor may decide participants should receive another drug, called cyclophosphamide, instead of fludarabine. In addition, depending on the results of participants' routine blood tests, participants may receive the drugs bortezomib and rituximab, which also help with immune suppression.
Recruiting
1 award
Phase 2
More about Maria Cancio, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Maria Cancio, MD has experience with
- Fludarabine
- Busulfan
- Clofarabine
- Cord Blood Graft
- Cyclosporine-A
- Mycophenolate Mofetil
Breakdown of trials Maria Cancio, MD has run
Bone Marrow Failure Syndrome
Hemoglobin Disorders
Myelodysplastic Syndrome
Myeloproliferative Disorder
Non-Hodgkin's Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maria Cancio, MD specialize in?
Maria Cancio, MD focuses on Bone Marrow Failure Syndrome and Hemoglobin Disorders. In particular, much of their work with Bone Marrow Failure Syndrome has involved Stage I patients, or patients who are Stage II.
Is Maria Cancio, MD currently recruiting for clinical trials?
Yes, Maria Cancio, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Maria Cancio, MD has studied deeply?
Yes, Maria Cancio, MD has studied treatments such as Fludarabine, Busulfan, Clofarabine.
What is the best way to schedule an appointment with Maria Cancio, MD?
Apply for one of the trials that Maria Cancio, MD is conducting.
What is the office address of Maria Cancio, MD?
The office of Maria Cancio, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.